Literature DB >> 1120164

The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides.

R B Naso, L J Arcement, G Wood, T E Saunders, R B Arlinghaus.   

Abstract

Rauscher leukemia virus (RLV) 65-S RNA, 35-S mengovirus RNA and reticulocyte A-rich RNA each stimulated cell-free protein synthesis in a JLS-V5 cell derived S-30 system. rRNA, however, was not stimulatory in this system. Of the stimulated protein products only those synthesized in response to added RLV RNA were immune-precipitable with anti-RLV rabbit serum. Furthermore, cell-free incubations with pactamycin at a concentration which specifically inhibits initiation and not elongation prevented the stimulation of amino acid incorporation in response to added RLV RNA. Analysis of the polypeptides synthesized by the cell-free system in response to reticulocyte A-rich RNA, showed them to be globin-like and, therefore, also mRNA specific. The RLV RNA-directed product included at least two classes of polypeptides (mol. wts of 140 000-185 000 and 50 000-75 000) both of which were larger than the group specific polypeptides of mature virions. None of the internal structural polypeptides of mature virions were synthesized in response to RLV RNA. The large molecular weight, viral-specific polypeptides are candidate precursor polyproteins which may represent the translational products of a polycistronic mRNA with a single initiation site.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120164     DOI: 10.1016/0005-2787(75)90261-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro.

Authors:  A L Gielkens; D Van Zaane; H P Bloemers; H Bloemendal
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

2.  Cell-free translation of virion RNA from nondefective and transformation-defective Rous sarcoma viruses.

Authors:  T Pawson; G S Martin; A E Smith
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

3.  Analysis of cytoplasmic RNA and polyribosmomes from feline leukemia virus-infected cells.

Authors:  A J Conely; L F Velicer
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

4.  Cell-free synthesis of the precursor polypeptide for avian myeloblastosis virus DNA polymerase.

Authors:  B M Paterson; D J Marciani; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

5.  Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA.

Authors:  L I Messer; J G Levin; S K Chattopadhyay
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

6.  Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA.

Authors:  J Ghysdael; E Hubert; M Trávnícek; D P Bolognesi; A Burny; Y Cleuter; G Huez; R Kettmann; G Marbaix; D Portetelle; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

7.  Analysis of intracellular feline leukemia virus proteins II. Generation of feline leukemia virus structural proteins from precursor polypeptides.

Authors:  G F Okasinski; L F Velicer
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

8.  Size and genetic content of viral RNAs in avian oncovirus-infected cells.

Authors:  W S Hayward
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  Translation of murine leukemia virus RNA in cell-free systems from animal cells.

Authors:  I M Kerr; U Olshevsky; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

10.  Analysis of intracellular feline leukemia virus proteins. I. Identification of a 60,000-dalton precursor of feline leukemia virus p30.

Authors:  G F Okasinki; L F Velicer
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.